| Microvesicle-associated AAV vector as a novel gene delivery system CA Maguire, L Balaj, S Sivaraman, MHW Crommentuijn, M Ericsson, ... Molecular Therapy 20 (5), 960-971, 2012 | 304 | 2012 |
| Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain KE Van Der Vos, ER Abels, X Zhang, C Lai, E Carrizosa, D Oakley, ... Neuro-oncology 18 (1), 58-69, 2015 | 300 | 2015 |
| Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9 E Rodriguez, K Boelaars, K Brown, RJ Eveline Li, L Kruijssen, ... Nature communications 12 (1), 1270, 2021 | 165 | 2021 |
| Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo B György, Z Fitzpatrick, MHW Crommentuijn, D Mu, CA Maguire Biomaterials 35 (26), 7598-7609, 2014 | 144 | 2014 |
| Triple bioluminescence imaging for in vivo monitoring of cellular processes CA Maguire, MS Bovenberg, MHW Crommentuijn, JM Niers, M Kerami, ... Molecular Therapy-Nucleic Acids 2, 2013 | 111 | 2013 |
| Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8 J Berenguer, T Lagerweij, XW Zhao, S Dusoswa, P Van Der Stoop, ... Journal of extracellular vesicles 7 (1), 1446660, 2018 | 84 | 2018 |
| Mouse gender influences brain transduction by intravascularly administered AAV9 CA Maguire, MHW Crommentuijn, D Mu, E Hudry, A Serrano-Pozo, ... Molecular Therapy 21 (8), 1470-1471, 2013 | 52 | 2013 |
| Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy STT Schetters, E Rodriguez, LJW Kruijssen, MHW Crommentuijn, L Boon, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 51 | 2020 |
| Mouse DC-SIGN/CD209a as target for antigen delivery and adaptive immunity STT Schetters, LJW Kruijssen, MHW Crommentuijn, H Kalay, J Ochando, ... Frontiers in immunology 9, 990, 2018 | 47 | 2018 |
| Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model MHW Crommentuijn, R Kantar, DP Noske, WP Vandertop, CE Badr, ... Molecular Therapy-Oncolytics 3, 2016 | 27 | 2016 |
| Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma MHW Crommentuijn, CA Maguire, JM Niers, WP Vandertop, CE Badr, ... Molecular oncology 10 (4), 625-634, 2016 | 22 | 2016 |
| A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer T Lagerweij, L Hiddingh, D Biesmans, MHW Crommentuijn, J Cloos, ... Oncotarget 7 (24), 35776, 2016 | 21 | 2016 |
| Immunological dynamics after subcutaneous immunization with a squalene‐based oil‐in‐water adjuvant STT Schetters, LJW Kruijssen, MHW Crommentuijn, H Kalay, ... The FASEB Journal 34 (9), 12406, 2020 | 17 | 2020 |
| Immune involvement of the contralateral hemisphere in a glioblastoma mouse model MHW Crommentuijn, STT Schetters, SA Dusoswa, LJW Kruijssen, ... Journal for immunotherapy of cancer 8 (1), 2020 | 10 | 2020 |
| The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment SA Dusoswa, J Verhoeff, S van Asten, J Lübbers, M van den Braber, ... Frontiers in immunology 15, 1343484, 2024 | 2 | 2024 |
| IMMU-20. SINGLE CELL CYTOMICS OF PERIPHERAL BLOOD MONONUCLEAR CELLS REVEALS NEW AVENUES FOR GLIOMA IMMUNOTHERAPY S Dusoswa, J Verhoeff, M Crommentuijn, T Würdinger, D Noske, ... Neuro-Oncology 20 (Suppl 6), vi125, 2018 | | 2018 |
| IMMU-30. HIGH-DIMENSIONAL PHENOTYPING OF IMMUNE SUBSETS AND CHECKPOINTS IN THE MOUSE GLIOBLASTOMA MICROENVIRONMENT M Crommentuijn, S Schetters, S Dusoswa, L Kruijssen, J Garcia-Vallejo, ... Neuro-oncology 20 (Suppl 6), vi127, 2018 | | 2018 |
| Development of vector-based strategies against glioblastoma MHW Crommentuijn | | 2017 |
| Mouse Gender Influences Brain Expression of a Reporter Gene by Intravascularly-Administered AAV9 CA Maguire, MHW Crommentuijn, D Mu, E Hudry, A Serrano-Pozo, ... MOLECULAR THERAPY 21, S208-S208, 2013 | | 2013 |
| A CHEMICAL SMALL MOLECULE SCREEN IDENTIFIES QUERCETIN AS A PUTATIVE RADIOSENSITIZER FOR THE TREATMENT OF MEDULLOBLASTOMA E Hulleman, T Lagerweij, D Biesmans, MHW Crommentuijn, J Cloos, ... NEURO-ONCOLOGY 14, 90-90, 2012 | | 2012 |
Johan SkogChief Scientific Officer, Vice President, Exosome Diagnostics, Bio-techne在 bio-techne.com 的电子邮件经过验证
